[Form 4] SBC Medical Group Holdings Inc Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
SBC Medical Group Holdings Inc Chairman and CEO Yoshiyuki Aikawa reported an open-market sale of 465,000 shares of common stock on April 28, 2026 at a net price of $3.0225 per share. The sale occurred on the closing date of the underwriters' option to purchase additional shares tied to an underwritten public offering that initially closed on April 21, 2026.
Following the transaction, Aikawa holds 78,839,460 SBC shares directly, plus indirect interests including 5,000,000 shares held by Aikawa Investment Co., Ltd., which he wholly owns, and an 861,600-share indirect interest through Aikawa Equity Management Co., Ltd., where he disclaims beneficial ownership except for his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Large CEO sale is small versus his remaining stake and linked to an offering.
Yoshiyuki Aikawa, SBC’s Chairman and CEO, sold 465,000 common shares at $3.0225 per share on April 28, 2026. The footnotes state this occurred under the underwriters' option for an underwritten public offering that initially closed on April 21, 2026, framing it as part of a broader capital markets transaction.
After the sale, he still directly owns 78,839,460 shares, plus 5,000,000 shares held via wholly owned Aikawa Investment Co., Ltd. and an 861,600-share indirect interest through Aikawa Equity Management Co., Ltd., where he disclaims broader beneficial ownership. Given the scale of his remaining position and the transaction’s link to the underwriters' option, this looks like a routine liquidity event rather than a thesis-changing move.
Insider Trade Summary
Net Seller: 465,000 shares ($1,405,463)
Net Sell
3 txns
Insider
Aikawa Yoshiyuki
Role
Chairman and CEO
Sold
465,000 shs ($1.41M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 465,000 | $3.0225 | $1.41M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 78,839,460 shares (Direct, null);
Common Stock — 861,600 shares (Indirect, See Footnote)
Footnotes (1)
- The price of $3.0225 represents the net price received per share of common stock of SBC Medical Group Holdings Incorporated ("SBC shares"), which were sold by the Reporting Person, on the closing date of April 28, 2026, pursuant to the underwriters' option to purchase additional shares in connection with an underwritten public offering that initially closed on April 21, 2026. The 861,600 SBC shares reported as indirectly beneficially owned by the Reporting Person through Aikawa Equity Management Co., Ltd. ("AEM") reflects the Reporting Person's indirect interest that he may be deemed to have shared beneficial ownership over for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. The Reporting Person owns 8,616 shares of AEM, which directly holds 5,284,500 SBC shares, and each share of AEM corresponds to one hundred SBC shares. The Reporting Person does not control AEM, and therefore, disclaims beneficial ownership over the SBC shares held by AEM, except to the extent of his pecuniary interest therein. Represents SBC shares held by Aikawa Investment Co., Ltd., a company wholly owned by the Reporting Person.
Key Figures
Shares sold: 465,000 shares
Sale price: $3.0225 per share
Direct holdings after sale: 78,839,460 shares
+5 more
8 metrics
Shares sold
465,000 shares
Open-market sale on April 28, 2026
Sale price
$3.0225 per share
Net price received under underwriters' option
Direct holdings after sale
78,839,460 shares
Common stock directly owned post-transaction
Indirect holdings via Aikawa Investment
5,000,000 shares
Shares held by wholly owned Aikawa Investment Co., Ltd.
Indirect interest via AEM
861,600 shares
Indirect interest in SBC through Aikawa Equity Management Co., Ltd.
AEM SBC holdings
5,284,500 shares
SBC shares directly held by AEM
AEM shares owned by Aikawa
8,616 shares
Each AEM share corresponds to 100 SBC shares
Net buy/sell direction
Net sale of 465,000 shares
transactionSummary netBuySellShares
Key Terms
underwriters' option, underwritten public offering, beneficial ownership, pecuniary interest, +1 more
5 terms
underwriters' option financial
"pursuant to the underwriters' option to purchase additional shares"
An underwriters' option is a short-term right given to the banks handling a new stock or bond sale to buy extra shares from the issuer, usually up to a fixed percentage, to stabilize the price after the offering. For investors this acts like a safety valve: it can reduce wild price swings by allowing underwriters to add or return shares as demand changes, which helps prevent a newly issued security from falling or spiking sharply.
underwritten public offering financial
"in connection with an underwritten public offering that initially closed"
An underwritten public offering is when a company sells new shares of its stock to the public with the help of a financial firm, called an underwriter. The underwriter agrees to buy all the shares upfront, reducing the company's risk, and then sells them to investors. This process helps companies raise money quickly and confidently from a wide range of buyers.
beneficial ownership financial
"may be deemed to have shared beneficial ownership over for purposes of Section 16"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership over the SBC shares held by AEM, except to the extent of his pecuniary interest therein"
Section 16 of the Securities Exchange Act of 1934 regulatory
"for purposes of Section 16 of the Securities Exchange Act of 1934, as amended"
A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.
FAQ
What did SBC (SBC) Chairman and CEO Yoshiyuki Aikawa report in this Form 4?
Yoshiyuki Aikawa reported selling 465,000 shares of SBC common stock at a net price of $3.0225 per share. The transaction occurred on April 28, 2026, tied to the underwriters' option in an underwritten public offering that initially closed on April 21, 2026.
Was the SBC insider sale connected to a public offering?
Yes. A footnote states that the 465,000 SBC shares were sold pursuant to the underwriters' option to purchase additional shares. This option was exercised in connection with an underwritten public offering that initially closed on April 21, 2026, with the option closing on April 28, 2026.
Does Yoshiyuki Aikawa control Aikawa Equity Management Co., Ltd. according to the Form 4?
The footnotes note that Aikawa does not control Aikawa Equity Management Co., Ltd. They explain he owns 8,616 AEM shares, each corresponding to one hundred SBC shares, and he disclaims beneficial ownership of SBC shares held by AEM except to the extent of his pecuniary interest.